Remedy publishes the financial statements release, two business reviews and the half-year review according to the disclosed annual schedule.
Event Date
Silent period and closed window 12.1.–11.2.2022
Financial statements release 2021 11.2.2022
Annual report, financial statements, Board of Directors’ report and Audit report for 2021 Week 12 / 2022
Silent period and closed window 13.4.–13.5.2022
Annual General Meeting 2022 13.4.2022
Business review for January-March 2022 13.5.2022
Silent period and closed window 13.7.–12.8.2022
Half-year review for January-June 2022 12.8.2022
Silent period and closed window 28.9.–28.10.2022
Business review for January-September 2022 28.10.2022

Regularly published financial reports are always preceded by a silent period of 30 days, during which Remedy does not issue statements on the financial position, business operations, markets or prospects.

During the silent period, the senior management of the company does not meet with investors, analysts or other capital market representatives, nor do they give interviews on the financial position of the company.